Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...

The F.D.A. is making its biggest move yet to end smoking. It needs to be careful not to give rise to another public health ...

Weight loss drugs like Ozempic and Wegovy are all the rage, but not everyone can afford them, and not everyone needs them to lose weight.

The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision ...

Alphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal ...

Right now, our state’s most vulnerable populations that rely on Medicare and Medicaid are unable to access anti-obesity ...

Although fast food can be a tasty treat, many of your favorite menu items contain some very questionable preservatives, dyes, ...

The rise of misinformation online has helped fringe health ideas go mainstream and eased RFK Jr.'s path to confirmation as ...

The Hendrix College Office of Engaged Learning has announced five Odyssey Professorships awarded to seven members of the ...

An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...

Amgen will continue to advance half of the combo, PRMT5 inhibitor AMG 193, for which it is running a mid-stage trial in ...

In recent years, there has been a noticeable increase in the number of men seeking natural remedies for prostate health. With ...